| Similar Articles |
|---|
 |
The Motley Fool
April 2, 2008
Brian Lawler |
A Slate of Data for Exelixis Exelixis will present analyses of study data at the American Society of Clinical Oncology in May for all of its lead cancer-fighting compounds. Investors, take note.   |
The Motley Fool
May 18, 2011
Brian Orelli |
5 Biotech ASCO Abstracts to Watch The biotech investors' Christmas in May is once again upon us, where investors and researchers alike will be able to find the synopsis of what will be presented at the American Society of Clinical Oncology annual meeting next month. |
Information Today
October 27, 2011 |
HighWire Press Uses TEMIS to Enrich Content Semantically Under the strategic technology and business partnership, HighWire will integrate the full suite of Luxid software within its ePublishing Platform to provide automated content annotation, enrichment, and linking to its customers. |
Information Today
February 25, 2014 |
HighWire Press Augments Articles With Altmetric Data HighWire Press and Altmetric, a London-based startup focused on scholarly literature, signed an agreement to offer altmetrics integration for publications hosted on the HighWire Open Platform. |
The Motley Fool
May 24, 2010
Brian Orelli |
ASCO Abstracts -- Pops and Drops! Ever since The American Society of Clinical Oncology began posting abstracts on-line -- and before that when they were sent to attendees -- investors have clamored to get a glimpse at the data. Here's your glimpse. |
Information Today
February 26, 2009 |
Royal Society Journals Launched on HighWire Platform The platform delivers the Royal Society's internationally renowned science journals, including the longest scientific journal archive, dating from 1665. It provides dramatically enhanced Web 2.0 functionality and library-friendly features. |
Information Today
January 30, 2014 |
Duke University Press Ebooks Find New Home Duke University Press teamed up with HighWire Press to create a new platform for the e-Duke Books Scholarly Collection, which will be found at read.dukeupress.edu. |
Information Today
March 31, 2008
Barbara Quint |
HighWire's New H2O Platform Updates Epublishing for Publisher Partners HighWire is an online repository for scholarly publications. Version 2.0 (H2O) will enable content to work with a variety of Web 2.0 applications, and it will allow publishers to expand their content types beyond journals to books, reference works, and non-journal web content |
Information Today
September 8, 2011 |
HighWire Introduces Five-Star Article Rating Feature on SAGE Open HighWire Press once again demonstrates its support of independent scholarly publishers with a tool designed for open access publications. |
Information Today
January 24, 2013 |
HighWire Press to Include e-Duke Books Scholarly Collection Beginning with the 2014 collection, e-Duke Books, an annual collection of at least 100 new electronic books published by Duke University Press as well as more than 1,500 backlist titles, will move from ebrary to HighWire's Open Platform and the newly developed Folio ebook solution. |
Information Today
October 17, 2013 |
HighWire Press Debuts Folio for Ebooks HighWire Press introduced Folio, an ebook solution for publishers that is designed to connect patrons with content on a user-friendly e-reading platform. |
The Motley Fool
June 2, 2009
Brian Orelli |
ASCO's Big Winner Despite the massive changes in value that some small-cap biotech companies have seen before and during this year's American Society of Clinical Oncology annual meeting, the big winner from the confab is actually large pharmaceutical companies. |
The Motley Fool
June 5, 2007
Brian Lawler |
Exelixis Presents The pharmaceutical presents data from 2 of its top drug candidates at ASCO. Investors, take note. |
Information Today
March 6, 2014 |
HighWire Usage Reports Are Now COUNTER 4-Compliant Institutional usage reports for hosted publications on the HighWire Press platform now include data complying with Release 4 of the COUNTER Code of Practice for e-Resources. |
Information Today
December 8, 2003
Barbara Quint |
HighWire Press Provides Open Packaging to Online Journal Subscribers Initiated by a group of scholarly society publishers participating in HighWire Press, the librarian-led journal aggregator, a new pricing/subscription model allows librarians to create their own packages using tiered pricing tied to library type. |
The Motley Fool
June 7, 2010
Brian Orelli |
Bristol Investors Go Crazy Wild. Are They Justified? Bristol-Myers Squibb is up a lot on an upgrade and some positive data coming out of the American Society of Clinical Oncology meeting, but investors need to be careful. |
Science News
May 13, 2000 |
Cancer Net CancerNet is a huge compendium of information on cancer assembled by the National Cancer Institute.... |
Pharmaceutical Executive
February 1, 2013
William Looney |
In Cancer, Process Drives Progress Today's most important public health story is the advance in our understanding of the biology of cancer. |
Scientific American
August 2008
Jessica Wapner |
Cancer Drug Costs May Help Doctors Select a Treatment In discussing treatments, cancer doctors plan to include cost. |
The Motley Fool
June 5, 2007
Billy Fisher |
Onyx on Fire It is readily apparent that investors in the biopharma will sink or swim on the future results of Nexavar. The ASCO meeting marks an integral win for the company, but only time will tell whether the drug can push the company into the black. |
BusinessWeek
May 28, 2009
Catherine Arnst |
Make-or-Break Time for Cancer Drugs Strong presentations at the key oncology conference in late May will be crucial for struggling biotechs. |
Information Today
February 6, 2012 |
SAGE Journals Available Via Mobile Devices SAGE announced that its entire online journal collection is now available in a mobile-optimized format with the help of HighWire Press' Mobile Web Interface. |
Information Today
March 22, 2004
Barbara Quint |
Sci-Tech Not-For-Profit Publishers Commit to Limited Open Access The DC Principles are a response to charges that current publisher practices impede access to published scientific research. |
The Motley Fool
June 6, 2007
Brian Lawler |
Is Telik Insane? Shares of Telik fall after the FDA puts a halt to trials with its lead drug. Even at this reduced share price, investors should stay far away from this pharma. |
Fast Company
July 1, 2007 |
Going on the Gold Standard What it takes for your company to join the cancer fight. |
The Motley Fool
June 9, 2010
Brian Orelli |
ASCO Pops and Drops Themes and company news from the annual meeting of the American Society of Clinical Oncology. |
The Motley Fool
April 13, 2007
Brian Lawler |
Genentech Is Still Healthy The biopharma powerhouse announces its first-quarter financial results. Investors, take note. |
Managed Care
March 2007
Lola Butcher |
Plans Put Greater Emphasis On Cancer Management Increasingly, health plans are rolling out services designed to help cancer patients and, before that, plan members at a high risk of cancer, to improve their health care and, in doing so, limit costs. |
The Motley Fool
May 10, 2005
Charly Travers |
The Future of Cancer Therapy Biotech firm Exelixis is blazing a trail for long-term success. Should investors take notice? |
The Motley Fool
May 28, 2009
Brian Orelli |
Make Money, Fight Disease: The ASCO Preview The big cancer meeting is upon us. |
Managed Care
October 2007
Lola Butcher |
Can Insurer, Oncology Practice Really Work Together? Premera Blue Cross and a large Spokane oncology practice agree on treatment protocols and on the importance of cost control. |
Managed Care
August 2007
Martin Sipkoff |
Soaring Price of Cancer Drugs Leads Plans To New Approaches Insurers are trying different methods, from pay for performance to promoting preventive care, to hold down cost of chemotherapy drugs. |
Pharmaceutical Executive
February 1, 2013
William Looney |
Pathways to Progress Cancer is increasingly understood as a collection of rare and mostly treatable conditions rather than the impregnable, monolith portrayed in popular culture. Industry experts review current and pending efforts to turn great science into good practice. |
Information Today
March 8, 2010 |
Two New Ebook Surveys Highlight Interesting Trends HighWire Press, a division of the Stanford University Libraries, has released the full results of a fall 2009 survey of librarians on their attitudes and practices related to ebooks |
ONLINE
November 2000
Mick O'Leary |
Grading the Library Portals The ideal library portal will have the most thorough coverage possible in several areas of the library profession for all types of libraries... |
Bio-IT World
March 2006
Charles Firneno |
Physician Portals Fill the Gap Multifunctional physician/patient portals can provide insight into value and product performance issues. Such insight can be combined with medical claims and pharmacy data as well as with blinded safety data to provide an organic view of product performance. |
The Motley Fool
July 16, 2007
Brian Lawler |
Slight Setback for ImClone ImClone announces a failed cancer study. Investors, take note. |
Pharmaceutical Executive
July 3, 2007
Sarah Houlton |
Global Report: Five-Year Survivor: European Edition The UK government's attitude seems to be that oncology treatments are hugely expensive -- and that too much of the National Health Service budget is vanishing into the pockets of drug companies. Will cancer networks fill the gap? |
The Motley Fool
May 29, 2009
Brian Orelli |
This Company Is Hot and Going Places Pharma company sanofi-aventis licenses a program, including two phase 1 compounds from Exelixis. |
Information Today
April 7, 2015 |
HighWire Press Rolls Out Collaboration and Content Collection Toolset HighWire Press launched Stackly, a web-based toolset for content collection, organization, storage, and peer-to-peer collaboration that integrates into publication sites so publishers can promote content and engage with researchers. |
The Motley Fool
June 22, 2004
Charly Travers |
Merck Pays Up for a Cancer Drug As demonstrated this morning with the announcement of a major deal with Vertex Pharmaceuticals, Merck is now in the midst of a strategic push to build out its oncology pipeline. |
Information Today
January 3, 2013 |
HighWire Incorporates Article-Level Metrics With ImpactStory ImpactStory aggregates impact data -- the number of times an article is accessed and mentioned in editorials, news, tweets and blogs, as well as bookmarked, favorited, and recommended, in addition to those cited by another research paper, from sources such as CrossRef, Mendeley, and PubMed. |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
Information Today
April 4, 2011 |
Copyright Clearance Center Launches Get It Now for Academic Institutions The service complements academic institutions' interlibrary loan (ILL) borrowing services by providing immediate fulfillment of full-text articles from unsubscribed journals 24 hours a day, 7 days a week. |
BusinessWeek
June 21, 2004
Catherine Arnst |
Cancer Superdrugs, Costly Side Effects New therapies are extending lives, but the prices could weigh down the nation. Oncologists, pharmaceutical companies, and the government will have to focus on the best way to lower prices for these drugs. |
Information Today
October 2000 |
OverDrive Provides E-Book Authoring Tools and Publisher Portals OverDrive, Inc. has announced the release of its ReaderWorks Standard software, which is available as a free download at OverDrive's Web portal... |
Managed Care
March 2007
Martin Sipkoff |
Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails. |
Information Today
December 8, 2015 |
HighWire Press Commits to Scholarly Annotation Initiative HighWire Press joined Annotating All Knowledge, an organization dedicated to exploring the benefits of building an open, common framework for scholarly annotation. |
The Motley Fool
March 26, 2007
Rich Duprey |
Acquisitions Mark Pharmaceutical Industry Japan's Eisai's newest acquisition continues the trend of pharmaceuticals buying up biotechs. Investors, take note. |
Information Today
October 13, 2003
Paula J. Hane |
Dialog Releases Dialog Portals Service Dialog has released Dialog Portals, its new service for integrating content into enterprise portals. A major selling point for the new offering is that it is compatible with nine of the leading portal software providers. |
